Telemedicine strategies improved anticoagulation management without increasing safety risks in older adults. The findings were presented at the European Society of Cardiology Congress 2025.

Patients on oral anticoagulants require close monitoring to maintain therapeutic levels and prevent thromboembolic events. A systematic review analyzed 39 clinical trials including 119,734 patients, with an average age of 75 years, evaluating telemedicine interventions such as self-testing with remote mobile management, computer-assisted dosing, laboratory-guided dose adjustments, and multitasking applications.

Use of telemedicine was associated with a significant increase in time in therapeutic range for patients on warfarin (mean difference 4.61, 95% confidence interval [1.60–7.62]). A trend toward reduced thromboembolic events was observed (relative risk 0.85, 95% CI [0.72–1.00]), while no differences were seen in mortality (RR 0.98, 95% CI [0.88–1.10]) or major bleeding (RR 0.92, 95% CI [0.81–1.05]).

These results indicate that telemedicine is a safe and effective approach to managing patients on oral anticoagulation, supporting wider adoption of remote monitoring and digital tools to improve therapeutic outcomes in clinical practice.